Counterfeit medicines have long been a topic with global implications, which countries are countering with legal regulations, among other things. Raw materials come from China or India, the subsidiaries are in Europe and the USA, and the drugs are distributed worldwide. Due to the global networking of the pharmaceutical industry, internationally active companies must comply […]
Since 1st July 2020, Russian Federal Law No. 425-FZ (Decree No. 1556) must be officially implemented by pharmaceutical manufacturers. Shortly before the deadline, the pharmaceutical industry tried to obtain a postponement. The new legislation, which will gradually be extended to include clothing, tobacco, and perfume, among others, is intended to prevent counterfeit medicines and black-market […]
Another customer relies on our solution to meet Russian serialization requirements on time. The Indian company Agio Pharmaceuticals Ltd. is now part of the tracekey network. We are very pleased to announce our cooperation with Agio Pharmaceuticals Ltd. Agio is a global pharmaceutical manufacturer and is active in the Russian market, among others. With Agio, […]
Read More… from Agio relies on tracekey for Russian requirements
Russia has been serializing since July 2020. The marking of Rx and OTC drugs with crypto codes is part of a large-scale track-and-trace project. It is intended to make an important contribution to greater patient and consumer safety in Russia. In addition to the safety aspect, however, economic interests are also in the foreground. Counterfeit […]
Read More… from Serialization in Russia: More than just a security measure
Pharmaceutical companies specializing in the production of over-the-counter drugs (OTC) have not been affected by pharmaceutical serialization so far. This is now changing for companies that are also active on the Russian market. The serialization requirements in Russia are much more complex than those of the EU-FMD. The so-called EU Counterfeiting Directive has been in […]